Front Page
- 14-day extension of lockdown likely (GS-2)
- CMs raise funds crunch with Modi (GS-3)
- Despite lockdown hurdles, sowing of summer crops up (GS-3)
- Migrant workers’ protest turns violent in Surat(GS-1)
FAQ
- To ease lockdown, what are the options? (GS-2)
- COVID-19 and immunity (GS-2/3)
Science
- COVID-19: younger patients develop fewer neutralising antibodies, study finds (GS-3)
- When should we blow the shofar?
- Coronavirus: two vaccines enter human trials, 60 in pre-clinical stage (GS-3)
- Why hospitals are hotbeds of coronavirus transmission (GS-2)
- Study indicates sex-specific differences in immune system (GS-3)
Business
- ‘We are at crucial point in agriculture, demand for inputs may see pick-up’ (GS-3)
- Over 30 crore poor get ₹28,256 cr. under PM Garib Kalyan Yojana (GS-2)
- Holdings in gold-backed exchange traded funds at all-time high in March (Prelims – ETF)
World
- U.S. reports highest daily death toll (GS-2)
- U.S. announces visa sanctions on nations refusing to accept citizens (GS-2)
- U.S. General meets Taliban leaders (GS-2)
- Crime drops globally as virus keeps people indoors
News
- Drug candidate, on trial, holds promise (GS-3)
- CM fund contributions to not qualify as CSR spend (Prelims – PM CARES SDRF NDRF)
- ‘Data is key to control of this pandemic’ (GS-2)
- SC urged to modify order on free COVID-19 testing by private labs (GS-2)
- ‘8.2 lakh cases if there was no lockdown’ (GS-2)
- States must evolve norms to help labourers return: Gadkari (GS-1/2)